DPYSL2 and cancer: From the perspective of CRMP2 expression patterns, CRMP2 is considered as a CRC biomarker [15], while s-CRMP2 is reported to control cell differentiation and proliferation, as well as correlate with poor prognosis of various cancers [12,16,29].